Yew Bio-Pharm Group Inc (YEWB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2020 | 03-2020 | 12-2019 | 09-2019 | 06-2019 | |
| Sales | 9,562 | 2,029 | 3,137 | 668 | 12,565 |
| Cost of Goods | 8,277 | 1,587 | 4,126 | 709 | 11,919 |
| Gross Profit | 1,285 | 442 | -989 | -41 | 646 |
| Operating Expenses | 706 | 872 | 879 | -405 | 429 |
| Operating Income | 857 | 157 | -1,742 | 1,072 | 1,136 |
| Other Income | -119 | -6 | -269 | 71 | 330 |
| Pre-tax Income | 738 | 151 | -2,011 | 1,143 | 1,466 |
| Income Tax | N/A | N/A | 1 | -41 | 30 |
| Net Income Continuous | 738 | 151 | -2,012 | 1,184 | 1,436 |
| Net Income | $738 | $151 | $-2,012 | $1,184 | $1,436 |
| EPS Basic Total Ops | 0.01 | 0.00 | -0.04 | 0.02 | 0.03 |
| EPS Basic Continuous Ops | 0.01 | 0.00 | -0.04 | 0.02 | 0.03 |
| EPS Diluted Total Ops | 0.01 | 0.00 | -0.04 | 0.02 | 0.03 |
| EPS Diluted Continuous Ops | 0.01 | 0.00 | -0.04 | 0.02 | 0.03 |
| EPS Diluted Before Non-Recurring Items | 0.01 | 0.00 | N/A | N/A | N/A |
| EBITDA(a) | $1,522 | $780 | $-1,409 | $1,744 | $-723 |